Steroids and drotrecogin alfa (activated) for severe sepsis

被引:0
|
作者
Steingrub, JS [1 ]
机构
[1] Baystate Med Ctr, Med ICU, Springfield, MA 01199 USA
关键词
D O I
10.1378/chest.124.5.2033
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:2033 / 2033
页数:1
相关论文
共 50 条
  • [1] Drotrecogin alfa (activated) in severe sepsis
    Baillie, JK
    Murray, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01): : 95 - 95
  • [2] Drotrecogin alfa (activated) in severe sepsis
    Poole, Daniele
    Rossi, Carlotta
    Addis, Antonio
    Livigni, Sergio
    Bertolini, Guido
    LANCET INFECTIOUS DISEASES, 2013, 13 (02): : 107 - 108
  • [3] Introduction: severe sepsis and drotrecogin alfa (activated)
    Artigas, Antonio
    Martin, Claude D.
    CRITICAL CARE, 2007, 11 (Suppl 5)
  • [4] Drotrecogin alfa (activated) in severe sepsis Reply
    Kalil, Andre C.
    LaRosa, Steven P.
    LANCET INFECTIOUS DISEASES, 2013, 13 (02): : 110 - 111
  • [5] Drotrecogin alfa (activated): the treatment for severe sepsis?
    Vincent, Jean-Louis
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (11) : 1763 - 1777
  • [6] Introduction: severe sepsis and drotrecogin alfa (activated)
    Antonio Artigas
    Claude D Martin
    Critical Care, 11
  • [7] Drotrecogin Alfa (Activated) in the Treatment of Severe Sepsis
    Vincent, Jean-Louis
    CURRENT DRUG SAFETY, 2007, 2 (03) : 227 - 231
  • [8] Treating severe sepsis with drotrecogin alfa (activated)
    Wyncoll, D
    HOSPITAL MEDICINE, 2003, 64 (03): : 168 - 172
  • [9] The development of drotrecogin alfa (activated) for the treatment of severe sepsis
    Macias, WL
    Yan, SB
    Grinnell, BW
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2004, 27 (05): : 360 - 370
  • [10] Clinical trials in severe sepsis with drotrecogin alfa (activated)
    Pierre-François Laterre
    Critical Care, 11